Generic drugs the pay-for-delay problem /
Saved in:
Corporate Author: | ebrary, Inc |
---|---|
Other Authors: | Curtin, Christina M. |
Format: | Electronic eBook |
Language: | English |
Published: |
New York :
Nova Biomedical/Nova Science Publishers,
c2011.
|
Series: | Public health in the 21st century series.
|
Subjects: | |
Online Access: | An electronic book accessible through the World Wide Web; click to view |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Generic drugs the pay-for-delay problem /
Published: (2011)
Published: (2011)
Pharmaceutical pricing policies in a global market
Published: (2008)
Published: (2008)
Pharmaceutical pricing policies in a global market
Published: (2008)
Published: (2008)
Les prix des medicaments sur un marche global politiques et enjeux.
Published: (2008)
Published: (2008)
Les prix des medicaments sur un marche global politiques et enjeux.
Published: (2008)
Published: (2008)
Generic drugs needs and issues /
Published: (2009)
Published: (2009)
Generic drugs needs and issues /
Published: (2009)
Published: (2009)
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Published: (1983)
Published: (1983)
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Published: (1983)
Published: (1983)
The $800 million pill the truth behind the cost of new drugs /
by: Goozner, Merrill, 1950-
Published: (2004)
by: Goozner, Merrill, 1950-
Published: (2004)
The $800 million pill the truth behind the cost of new drugs /
by: Goozner, Merrill, 1950-
Published: (2004)
by: Goozner, Merrill, 1950-
Published: (2004)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
by: Osmane, Malik
Published: (2014)
by: Osmane, Malik
Published: (2014)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
by: Osmane, Malik
Published: (2014)
by: Osmane, Malik
Published: (2014)
Driving down the cost of drugs : battling big pharma in the statehouse /
by: Castellblanch, Ram�on, 1948-
Published: (2012)
by: Castellblanch, Ram�on, 1948-
Published: (2012)
Driving down the cost of drugs : battling big pharma in the statehouse /
by: Castellblanch, Ram�on, 1948-
Published: (2012)
by: Castellblanch, Ram�on, 1948-
Published: (2012)
Pharmaceutical economics and policy
by: Schweitzer, Stuart O.
Published: (2007)
by: Schweitzer, Stuart O.
Published: (2007)
Pharmaceutical economics and policy
by: Schweitzer, Stuart O.
Published: (2007)
by: Schweitzer, Stuart O.
Published: (2007)
The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Published: (2003)
Published: (2003)
The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Published: (2003)
Published: (2003)
Profits before people? ethical standards and the marketing of prescription drugs /
by: Weber, Leonard J., 1942-
Published: (2006)
by: Weber, Leonard J., 1942-
Published: (2006)
Profits before people? ethical standards and the marketing of prescription drugs /
by: Weber, Leonard J., 1942-
Published: (2006)
by: Weber, Leonard J., 1942-
Published: (2006)
Marketing strategies adopted by generic and original drugs companies in an effort to attain strategic competitiveness: a study of Mombasa /
by: Matingi, Ireen Mueni
Published: (2013)
by: Matingi, Ireen Mueni
Published: (2013)
CAPA for the FDA-regulated industry /
by: Rodríguez Pérez, José, 1961-
Published: (2010)
by: Rodríguez Pérez, José, 1961-
Published: (2010)
CAPA for the FDA-regulated industry /
by: Rodríguez Pérez, José, 1961-
Published: (2010)
by: Rodríguez Pérez, José, 1961-
Published: (2010)
The risks of prescription drugs
Published: (2010)
Published: (2010)
The risks of prescription drugs
Published: (2010)
Published: (2010)
ADME-enabling technologies for drug design and development
Published: (2012)
Published: (2012)
ADME-enabling technologies for drug design and development
Published: (2012)
Published: (2012)
Drug discovery and design medical aspects /
Published: (2002)
Published: (2002)
Drug discovery and design medical aspects /
Published: (2002)
Published: (2002)
Drugs : from discovery to approval /
by: Ng, Rick
Published: (2015)
by: Ng, Rick
Published: (2015)
Drugs : from discovery to approval /
by: Ng, Rick
Published: (2015)
by: Ng, Rick
Published: (2015)
Similar Items
-
Generic drugs the pay-for-delay problem /
Published: (2011) -
Pharmaceutical pricing policies in a global market
Published: (2008) -
Pharmaceutical pricing policies in a global market
Published: (2008) -
Les prix des medicaments sur un marche global politiques et enjeux.
Published: (2008) -
Les prix des medicaments sur un marche global politiques et enjeux.
Published: (2008)